Integrative Biology
INTRODUCTION
Endothelial cells (EC) play a dual role in regulating platelet function. They constitutively secrete the platelet inhibitors nitric oxide (NO), prostacyclin and ADPases in a shear stress dependent manner to ensure that platelets do not spontaneously aggregate in the vasculature. 1 When activated by oxidative, mechanical, or inflammatory stresses EC promote platelet recruitment to the vessel wall by expression of E-selectin and the release of Weibel-Palade bodies. Weibel-Palade bodies contain von Willebrand factor (vWF) and P-selectin which support platelet rolling and accumulation.
2 Activated EC also retract from each other revealing an extracellular matrix consisting of collagen, laminin and fibronectin, among other proteins, that support platelet adhesion and activation. 3, 4 The spatial and temporal expression of these pro-and antithrombotic pathways likely determines, in part, the size and growth of a thrombus. Yet, there are no in vitro models of platelet function that incorporate a spatially controlled region of EC expressing a prothrombotic phenotype surrounded by EC region expressing an antithrombotic phenotype. The objective of this study was to develop such a model.
In vitro flow assays for measuring platelet function generally fall into two categories; adhesion to subendothelial matrix proteins and rolling/adhesion to activated EC. In the former, purified proteins are adsorbed to a substrate, typically a glass slide or capillary tube, and blood is perfused at user-defined wall shear rate. [5] [6] [7] [8] [9] Collagen, fibrinogen and vWF are the most common proteins used for measuring platelet function and tissue factor can be incorporated to study coagulation as well. 10 Combinations of these and other proteins give a range of platelet adhesion and aggregation responses. 11 Flow assays that include monolayers of cultured EC typically involve stimulation by chemical, mechanical and laser methods. [12] [13] [14] For example, exposure to inflammatory agents such as TNF-α and interleukin-1 leads to P-selectin exposure on EC, among other prothrombotic molecules, and the recruitment of platelets. 11, 15 Stimulation of endothelialized microfluidic channels with TNF-α and shiga toxin mimics the pathology of microvascular diseases such acute inflammation and hemolytic uremic syndrome. 16 PMA stimulated EC in microvascular networks embedded in collagen gels show the importance of channel geometry on platelet-vWF interactions. 17 The focal nature of a vascular injury is an important feature in the regulation of thrombus formation. A threshold injury size is needed to support platelet adhesion 18 , initiate coagulation 19, 20 and fibrin deposition. 21, 22 Moreover, ECs within and adjacent to an injury likely play different roles. Activated ECs within or very close to an injury support thrombus formation via secretion and expression of adhesive ligands, while those up and downstream limit platelet accumulation to the injury region. No in vitro model that we are aware of captures these different roles of ECs in a focal injury model.
In this study, we describe a vascular injury model where EC cultured within microfluidic channels are focally activated by heat using microelectrodes beneath the channels. This approach allows spatial and temporal control of an EC activation zone that supports platelet adhesion and accumulation surrounded by quiescent EC.
MATERIAL AND METHODS

Materials
Human umbilical endothelial cells (HUVEC), F-12K medium, Trypsin-EDTA, and Penicillin Streptomycin (10,000 IU/mL Penicillin, 10,000 µg/mL Streptomycin) solution were from American Type Culture Collection (ATCC, Manassas, VA). PE/Cy5 (480 nm/670 nm) antihuman CD41, annexin V and PE anti-human CD62E antibody were from BioLegend (San Diego, CA). Anti-integrin α 6 antibody (GoH3), anti-humanVE Cadherin antibody produced in rabbit, anti-human fibronectin antibody produced in rabbit, anti-human collagen I antibody produced in mouse, anti-human collagen IV antibody produced in mouse, goat anti-mouse IgG MI). Complete cell culture media (includes 100 IU/mL penicillin, 100 µg/mL streptomycin, 0.1 mg/mL heparin, 0.05 mg/mL ECGS, and 10% fetal bovine serum) and serum free media were made in-house.
Fabrication of microelectrodes
Glass slides were stripped of organic and ionic contaminants by RCA-1 (deionized . KMPR was removed from the contact pads by photolithography and silver epoxy was spread on the contact pads of the electrodes as an adhesive for wiring to the power source (Suppl . Fig 1) .
Thermal infrared camera measurement
A 40 µm slab of PDMS was placed on the surface of insulated microelectrode. An infrared thermal imaging camera (FLIR Exx series, Wilsonville, OR) recorded the surface temperature as a function of voltage and time.
Endothelial cell seeding and culture in microfluidic channels PDMS microfluidic channels were fabricated using standard methods with KMPR patterned on a silicon wafer used a master. 23 The device consisted of four channels with a width of 1000 µm and height of 100 µm and was bonded to a 40 µm PDMS film (Suppl . Fig 1) . The PDMS film was prepared by spinning 10:1 base:catalyst PDMS at 1500 rpm on glass slides treated with (tridecafluoro-1,1,2,2-tetrahydooctyl)trichlorosilane for 3 h under vacuum. The devices were treated with oxygen plasma and then bonded to the PDMS film, which formed the bottom wall of the channel. Channels were sterilized with 70% ethanol for 10 min, flushed with serum free F-12K and then stored in an incubator for 12-18 hr at 37 °C and a relative humidity of 95%. The long incubation was required to ensure that all absorbed ethanol was removed the PDMS prior to introduction of the cells. Fibronectin (50 µg/ml) in serum free media was incubated in the channels for 2-4 hours. The channels were rinsed with complete F-12K and seeded with HUVEC at a concentration of 300,000-500,000 cells/mL in 6.25% dextran modified buffer to increase the viscosity to 3.5 cP at150 s -1 as measured by a DHR-3 rheometer (TA Instruments, New Castle, DE). Dextran was added to decrease cell settling and enhance seeding density staying below the concentration of dextran in which EC viability and attachment is affected. 16, 24 Fresh complete F-12K was replaced over the cells on a daily basis. Confluence and tight junctions were achieved within two days and cells were used for experiments within 2-3 days of seeding (Suppl. Fig 2) .
Blood collection and treatment
All blood collection was performed in accordance with the Declaration of Helsinki and under the University of Colorado, Boulder Institutional Review Board approval. Human whole blood was obtained from donors through venipuncture. Donors had not consumed alcohol for 48 h, nor taken any prescription or over-the-counter drugs during the 10 days prior to donation. Five milliliters of whole blood were collected into vacutainers containing the PPACK (75 mM).
Samples were incubated with anti-human CD41 at 1:25 dilution for 20 min. In some experiments, whole blood was incubated with 100 µg/mL abciximab (GPIIbIIIa antagonist), anti- for 60 min.
Whole blood flow assays
HUVEC-seeded microfluidic channels were transferred onto glass slides containing the patterned and insulated electrode (Suppl. Fig. 1 ). Experiments were performed in a heated microscope incubator at 37°C and 5% CO 2 (INUG2A ZILCS, Tokai Hit). After allowing for temperature equilibration of the device and electrode for 10 min, voltage (5-9 V) was applied for 30 s either during whole blood perfusion or 2 min prior to whole blood perfusion. In the experiments where heat was applied during the blood perfusion, blood was perfused through the channel for 30 s prior to heating, the voltage was then applied for 30 sec while the blood was flowing and for 6 min after the heating was stopped. In experiments where heat was applied prior to perfusion, 6.25% dextran modified complete media was withdrawn at 15 µL/min using a syringe pump (PHD 2000, Harvard Apparatus) during and 1 min after the applied voltage. Next, whole blood was perfused at flow rate of 15 µL/min or 100 µL/min, corresponding to a wall shear rates of 150
and 1000 s -1 , for 7 min. For 1000 s -1 , the flow was ramped using a programmable syringe pump from 5 to 100 µL/min over 1 min to avoid EC sloughing off the surface.
Measurement of platelet accumulation on ECM proteins
Fibronectin (100 µg/ml), laminin (100 µg/ml) or a 1:1 mixture of the proteins (50 µg/ml:50 µg/ml) were incubated on clean glass slides in FAST frame multislide plate containing incubation chambers (Whatman, GE Healthcare Sciences) for 1 h. 25, 26 Next, whole blood collected into PPACK was perfused over the prepared protein patches (5 mm × 5 mm) at flow rate of 15 µL/min (150 s -1 ) for 7 min. Controls were conducted to determine the effect of heating on the ECM proteins. Fibronectin (100 µg/ml) or a 1:1 mixture of fibronectin/laminin (50 µg/ml:50 µg/ml) were incubated inside the microfluidic channels for 1 h. We applied 7 V in fibronectin and laminin/fibronectin coated channels while flowing buffer at 150 s -1 for 30 s.
After 1 min of cooling, whole blood collected into PPACK was perfused over the heat-treated proteins for at a flow rate of 15 µL/min (150 s -1 ) for 7 min.
Image analysis
Transient platelet accumulation was monitored using an inverted microscope (IX81, Olympus, 
Theoretical model of heat transfer
The change in temperature within the HUVEC coated channel caused by the heat flux from resistive heating of the microelectrode was estimated using finite element method software (COMSOL, Burlington, MA). Two models were developed; (1) a model of the bare electrode to compare with infrared camera measurements (Suppl. Fig 3A) , and (2) 
where i denotes the material, T is the temperature, t is time, ρ i is the material density, C p,i is the material heat capacity, and k i is the material thermal conductivity. Q is the heat source that was set to zero for all materials except for the gold. The heat source was modeled as a 30 s rectangular square wave of voltage and the power density was calculated at each voltage by:
where P v is the power density, V is the voltage, ρ is the bulk resistivity of gold (24 nΩ m -1 ), and L is the length of the electrode. Table 1 shows the materials and thermal properties used in the model. 
The velocity (v) was defined as:
where p is the gradient of pressure, µ is the dynamic viscosity. The average velocity (U) was 2.5 × 10 -3 m s -1 .
For both models, the boundary condition at all surfaces except for the bottom surface was free convection with air:
where T ext is 37 °C and the heat transfer coefficient was calculated from the simplified convection formula over a flat plate:
where h is overall heat transfer coefficient, T s is the surface temperature which varies over the surface, T ext is the ambient temperature, L is characteristic length (1.45 mm), and C and n are constants defined as 1.32 and 0.25, respectively. A Neumann boundary condition was used at the bottom of the glass slide:
where q is the heat flux (W/m 2 ) from the microelectrode glass slide to the glass surface underneath. Mesh independence was confirmed by achieving temperatures within a 5% difference between 6,734 -34,909 elements in Model 1 and 18,521-159,706 elements in Model 2.
Statistical procedures
Data are presented as a mean ± the standard error of the mean of 3-5 donors for each experimental condition. Differences in platelet volumes were compared using the Mann-Whitney
RESULTS
Electrode characterization
The temperature distribution resulting from resistive heating of the microelectrodes was measured and modeled as a function of voltage. Fig. 1A -B show the temperature distribution on and around insulated microelectrodes without the PDMS device. Applying potential of 5-9 V for 30 sec produced peak temperature increases of 20-70 °C as measured with a thermal imaging camera. The goodness-of-fit between Model 1 (Suppl. Fig. 3A ) and the experimental results was greater than 0.9 for each voltage (Fig. 1A) . These results show that the Model 1 predicts accurate heat fluxes due to resistive heating in the microelectrode. As expected, in the absence of forced convection the peak temperature is centered over the electrode and decreases symmetrically in the x-direction (Fig. 1B) . (Fig. 1D) . The temperature was skewed downstream of the electrode due to heat transfer by forced convection.
Viability of EC and activation following heating
PDMS microfluidic channels with confluent EC monolayers were placed over the electrodes (Suppl. Fig. 2 ). Dextran modified complete media was perfused through the channels at a wall shear rate of 150 s -1 while a 5-9 V potential was applied for 30 s. Following two additional minutes of buffer perfusion, cells were fixed and stained for viability (ethidium bromide), Pselectin, and phosphatidylserine (PS) exposure (annexin V). At 5 and 6 V, little to no P-selectin expression and cell death was observed ( (Fig. 2A) . P-selectin positive EC spanned 1.5 mm upstream of the injury zone to 4 mm downstream of injury center (Fig. 2B) . The distribution of dead and activated EC skews downstream, which is congruent with the predicted temperature distribution by Model 2 (Fig. 1D ).
Moderate heating leads to retraction of EC that reveals a protein-rich matrix
The contact between the EC were lost and gaps between EC increased in a voltage-dependent manner. There were no apparent gaps between EC at 5 and 6 V. A potential of 6.5 V yielded a 30% decrease in EC area directly over the electrode and observed gaps up to 2.5 mm downstream of the electrode (Fig. 3A,B) . A potential of 7 V lead large gaps up-and downstream, but very small gaps directly over the electrode (Fig. 3C,D) . Similarly, a potential of 8 V led to small gaps near the electrode with the largest gaps present coverage 2.5-3.7 mm downstream (Fig. 3E,F) . These data suggest that a moderate amount of heating cause EC to lose their tight junctions and retract, but that above a certain temperature retraction is reduced or EC do not retract before losing viability. The exposed matrix under receded EC was rich in laminin, collagen IV and fibronectin with only a modest amount of collagen I (Fig. 4) .
EC secrete and release VWF strands following heating
After applying voltage, the presence of vWF strings on EC was measured along the length of the channel (Fig. 5A ). Approximately 10% of EC secreted vWF strings even far upstream (x = -3 mm) of the electrode where we expect no heating (Fig. 5B) . In regions where heating is predicted to be highest (Fig. 1B) , 1 mm upstream to 3 mm downstream of the electrode, there were threefold as many vWF strings compared to unheated regions. The release of vWF increased with increasing voltage; 88 ± 9 vWF strings were released at 8 V compared to 25 ± 9 vWF strings at 6 V ( Fig. 5C ).
Simultaneous heat injury and whole blood perfusion
PPACK anticoagulated whole blood was perfused over EC during the 30 sec voltage pulse and for 6 min afterwards at 150 s -1 . At 5-6 V, few platelets adhered to the surface, and few aggregates formed. At 7 V, we observed significant platelet accumulation with volumes of 45,000 ± 11,000 µm 3 at the downstream edge of the electrode (Fig. 6A , Suppl. Fig 5A) . Most aggregates were observed from the center of the electrode to 1.5 mm downstream. At 8 V, platelet aggregate volumes were five-fold larger, 220,000 ± 35,000 µm 3 , than aggregates formed at 7 V and found primarily downstream of the electrode (Fig. 6B ).
Computational Model 2 predicts heating of not only the ECs, but penetration of heat across the height of the channel. There was only a 6% difference in peak temperatures between the bottom and top of the channel at x = 0 (Suppl. Fig. 6 ). We measured platelet adhesion to fibronectin coated channels in the absence of ECs at 5, 6, 7 and 8 V and a wall shear rate of 150 s -1 (Suppl. Fig 7) to test the effect of heating in the absence of EC. There was no platelet adhesion at 5 V and minor adhesion at 6 V (Suppl. Fig 7A) . However, significant platelet aggregation was observed at 7 and 8 V, suggesting that the temperature increases experienced by platelets was enough to activate them (Suppl. Fig. 7B,C) . At 7V, there was a downstream shift in the distribution of the platelet aggregates (Suppl. Fig. 7B ), perhaps due to a lag time between heating and activation. Similarly, significant platelet adhesion and aggregation was also measured in a BSA coated channel exposed to 7V (Suppl. Fig. 7D ). In any case, these data indicate that it would be difficult to decouple platelet accumulation due to EC activation and exposure of the subendothelial matrix from heat-induced platelet activation and adhesion in this model.
Whole blood perfusion following heat injury
To eliminate the influence of temperature on platelets, we heated under conditions that induced gaps between EC (6.5 -8 V, Fig. 3 ) for 30 s while perfusing buffer through the channel followed by a 1 min cooling period and then a perfusion of whole blood for 7 min. At 6.5 V, corresponding to a predicted peak temperature increase of 19 °C, platelets accumulate directly over the electrode and downstream of the electrode with a skewed distribution (Fig. 7A,B) .
Platelet volumes reached a maximum size of 11,700 ± 5,000 µm 3 . At 7V, which had a peak temperature increase of 22 °C, the distribution was bimodal with peaks of platelet accumulation 1.5 mm upstream and 1.5 mm downstream of the electrode injury (Fig. 7C,D) . The upstream peak had aggregates that reached 4,700 ± 1,000 µm 3 while platelet aggregates reached 10,400 ± 1,700 µm 3 downstream of the electrode. Directly over the electrode there was little platelet accumulation. A similar trend was observed at 8 V, with a peak in platelet accumulation 1.5 mm upstream of the electrode and more substantial platelet accumulation 2-4 mm downstream. Peak volumes of the platelets reached 3,900 ± 1,000 µm 3 upstream of the injury and 13,100 ± 2,500 µm 3 downstream of the injury (Fig. 7E,F) . Platelet adhesion correlated with the predicted temperature found at a give position for each voltage. For example, accumulation was found at predicted temperature increases of 16 -22 °C. Changes in predicted temperature increases exceeding 23 °C resulted in EC death and little to no platelet accumulation. At 7 and 8 V the EC directly over the electrode had little recession and almost no platelet accumulation (Fig. 7C,E) .
Downstream of the electrode at 7 V, large gaps between ECs and significant platelet accumulation in these gaps was observed (Fig. 7C ).
Real-time measurement of platelet accumulation show platelet aggregates grow for the first 2-3 min of the assay on top of and between EC, followed by some shedding of loosely adhered platelets and platelet aggregates on top of EC (Suppl. Fig. 8 ). Firm platelet aggregates only remained in the retracted spaces between P-selectin positive EC.
At 7 V, whole blood perfusion at 1000 s -1 showed similar aggregate volumes as at 150 s -1 injury (Suppl. Fig. 9 ). A bimodal distribution had peak volumes of 4,600 ± 1,800 µm 3 upstream of the electrode and 8,600± 1,900 µm 3 downstream of the electrode. These data show that the model can support platelet adhesion at both venous and arterial shear rates, but that the final volume of platelet aggregates is not strongly dependent on shear rate.
Platelet adhesion between heat activated EC is mediated by GPIbα and α 6 β 1 receptors
During the flow assay, platelets rolled on EC, but permanent deposition was only observed in the gaps between EC. Because vWF strings were released by heat-activated EC (Fig. 5) , we expected that platelet adhesion is at least partially supported by GPIbα-vWF interactions. Indeed, inhibition of GPIbα resulted in a three-fold reduction in peak platelet aggregate volume over the electrode on EC stimulated by 6.5 V (Fig. 8A) . EC secrete laminin 28 and we found that in this model the matrix beneath EC was laminin-rich (Fig. 4) . Platelets can firmly adhere on laminin through the integrin α 6 β 1 at venous shear rates as used in these experiments. 29 In the presence of an anti-α 6 function-blocking antibody there was a dramatic reduction in platelet accumulation and almost no visible aggregation (Fig. 8) . Inhibition of α IIb β 3 was a negative control that resulted in no aggregation and only individual platelets adhered between the EC (Fig. 8) .
Combining anti-α 6 β 1 with either anti-α IIb β 3 or anti-GPIbα lead to near complete inhibition of platelet adhesion (Fig. 8A,B) .
To compare the EC secreted extracellular matrix to purified proteins, platelets were perfused over surfaces of laminin and fibronectin and a 1:1 mixture of both. These proteins were chosen because fibronectin is used for seeding EC and laminin is abundent in the ECM (Fig. 4) .
Collagen IV is also abundant, but platelets do not express any known receptors for collagen IV.
A mean platelet volume of 73,900 µm 3 accumulated over a 1:1 mixture of laminin and fibronectin (Suppl. Fig. 10 ). Mean volumes of 1,160 µm 3 and 22,000 µm 3 were measured on fibronectin and laminin, respectively. These conditions were compared to platelet aggregate volumes obtained on heat-treated EC at the position of the maximum size (Fig. 7) . Platelet aggregate volumes were normalized by the area available for adhesion ( Excessive heating of ECM proteins can alter their adhesive properties. Applying 7 V for 30 sec to a mixed laminin-fibronectin surface, but not fibronectin alone, resulted in diminished platelet adhesion at the hottest predicted position of the channel, directly downstream of the electrode (Suppl. Fig. 11 ). There was little to no platelet adhesion at this same position in the presence of EC (Fig. 7) . In simultaneous heat injury and blood perfusion experiments, maximum platelet accumulation occurred at this position suggesting platelet activation and integration was an artifact of heating (Fig. 6 ). 
Correlating EC activation, viability and platelet accumulation with temperature
DISCUSSION
The objective of this study was to develop an in vitro focal injury model in which an area of activated EC that would promote platelet adhesion were surrounded by an area of quiescent EC that would inhibit platelet activation. We used resistive heating of a surface microelectrode to provide a heat source to focally stimulate cultured EC in microfluidic channels. Computational models were developed to aid in the interpretation of experimental results and predict the temperature distribution as a function of flow conditions and applied potential. We used EC activation markers, EC recession, and viability to characterize the response of EC to elevated temperatures. Whole blood flow assays showed that millimeter-scale EC activation zones could be achieved that supported firm platelet adhesion and aggregation, primarily through GPIbα and
Predicted heating from computational models were correlated to different zones of EC activation and platelet accumulation. A kill zone corresponded to peak temperature increases of greater than 23 °C characterized by EC death, elevated levels of P-selectin, PS exposure and vWF secretions, but did not support platelet adhesion. An activation zone corresponded to peak temperature increases of 16-22 °C characterized by viable EC, elevated levels of P-selectin and vWF, significant recession of EC, exposing the underlying extracellular matrix, and supported robust platelet adhesion and aggregation. A quiescent zone corresponded to peak temperature increases of less than 15 °C characterized by EC that were viable, did not show an increase in Pselectin or vWF secretion compared to unheated cells, and did not support platelet adhesion. The transition between the kill zone and activated zone is apparently quite sensitive to temperature since we observed little activation at 6 V (predicted temperature = 15 °C) over the electrode and significant levels of cell death at 7 V (predicted temperature = 23 °C) and 8 V (predicted temperature = 30 °C). At 6.5 V (predicted temperature = 19 °C) we were able to focally activate EC and promote platelet adhesion without significant cell death. The transitions between these phenotypes were not sharp, but rather follow the gradients in predicted surface temperature.
Observations in this injury model were consistent with other in vitro and in vivo injury models of heat-induced cell injury. In a baboon heat stroke model, exposure to environmental heat stress until a core temperature of 42.5 °C was attained caused widening of gaps between the EC, increased content release of the Weibel Palade bodies, tissue factor exposure, and endothelial cell-platelet interactions. 30 Many of these features were also observed in our microelectrode heating model. Other in vitro models have shown cell death after hyperthermia, as we observed at peak temperature changes greater than 23 °C. For example, murine mastocytomas subjected to temperature increases 42 -47°C have accelerated apoptosis and necrosis as the thermal dose is increased. 31 In our model, platelet accumulation was completely abolished directly over the electrode at 7 and 8 V, which corresponded to 25-40 °C temperature increases in our computational model.
As was shown in our control experiments performed with ECM proteins, platelet adhesion was not supported just downstream of the electrode after 7 V had been applied. Bos et. al also demonstrated decreased platelet adhesion to thermally injured subendothelium after 15 s of exposure to elevated temperatures, which was largely attributed to denaturation of VWF 32 .
Decreases of 25%, 50% and 75% platelet accumulation on the ECM were found to occur at temperatures increases of ~ 32, 35 and 38 °C.
Heat-induced EC activation recreates some features reported in laser injury models of thrombosis. The matrix proteins that are exposed in this model depend on the degree of the injury. Moderate laser power can yield superficial vessel injuries in which the EC layer is denuded, exposing the subendothelial matrix, without significant exposure of the vessel wall. 33 In this case, platelet adhesion is mediated primarily by laminin, vWF, and type IV collagen, all of which are present in the ECM exposed in our heat injury model. Importantly, the data presented here show ECM proteins and platelet adhesion are significantly influenced by even modest temperature changes. Therefore, laser intensities that either alter the structure of ECM proteins or directly heat platelets, could influence initial platelet adhesion in these models.
Heat-induced EC activation recreates aspects of chemical injuries induced by calcium ionophores or staurosporine. Staurosporine, a nonspecific protein kinase inhibitor, causes EC to undergo apoptosis and support platelet adhesion 34, 35 . High temperatures in our heat injury model lead to EC death and exposure of PS, however these areas to do not support platelet adhesion, possibly due to denaturation of ECM proteins. Calcium ionophores can be used to induce secretion of Weibel-Palade bodies 36 , supporting transient platelet adhesion via GPIbα, but not firm adhesion and aggregation 37 . The combined release of Weibel-Palade bodies and EC recession were necessary for firm platelet adhesion in the heat injury model. A distinct advantage of our electrode heat injury over these chemical injuries is the spatial control of EC activation.
Platelet accumulation in the EC activation zone was mediated by GPIbα and α 6 β 1 receptors. Inhibition of GPIbα resulted in less rolling over EC, but platelets were still able to adhere in the gaps between receded EC. At the lower shear rates used in this study (150 s -1 ),
GPIbα is not necessary for platelet adhesion, but likely aids platelet recruitment to the EC surface and aggregation through vWF. Previous in vivo and in vitro studies show a supporting role for GPIbα mediated adhesion and activation at low shear rates. 25, 38, 39 Platelet accumulation was also supported at a high shear rate (1000 s -1 ) in the model, where vWF supported rolling is necessary for platelet adhesion. Interactions between the integrin α 6 β 1 and the extracellular matrix between EC were necessary for robust platelet adhesion and aggregation. Platelet adhesion to laminin is mediated by integrin α 6 β 1 . 40 A 69% and 82% reduction in thrombus volume is reported in guidewire and moderate laser injury models, respectively, with an α 6 -/-mouse. These results are also supported studies that platelet adhesion and aggregation are dependent on synergistic interactions between α IIb β 3 , α 6 β 1 and α 5 β 1 on the ECM of carotid arteries that have been dissected and ligated with a surgical filament to induce injury. 41 Cumulative platelet accumulation and their spatial distribution were influenced by EC phenotype. Platelets firmly adhered and aggregated only in the gaps between the retracted EC.
Moreover, platelet aggregate volumes were smaller in these gaps than on laminin-fibronectin surfaces. There was also little difference in platelet aggregates formed at average wall shear rates of 150 and 1000 s -1 , in contrast to in vitro flow assays on purified proteins 42 . These observations may be due to platelets favoring adhesion in the low shear stress valleys between EC or by secretion of platelet inhibitors such as NO. 43 We have previously shown the mass transfer limitations of NO inhibition of platelet aggregation as a function of shear rate using NO release from polymers. 44, 45 Of note was the prediction that NO would only be an effective platelet inhibitor within tens of micrometers of an adhesive surface, which is the case for the gaps between EC in the activation zone in the heat-injury model presented here. Future studies are needed to determine the relative roles of rheology, transport and the pro-and anti-platelet mechanisms of EC on platelet accumulation as a function of injury size and this model may provide a valuable tool for exploring these interactions.
While temperature was not measured directly in microfluidic channels, we used a computational model to make predictions of the temperature distribution. Even if there were discrepancies between the model and experiment in the absolute temperature, the relative differences between applied potential were likely well predicted by the model since the temperature and applied voltage were linearly proportional. EC response to mechanical and oxidative stresses depends on both the magnitude and duration of the insult. 46 We would expect the same hold true for temperature, but here, we limited studies to a constant duration of heating of 30 sec. Simultaneous heating and whole blood perfusion caused platelet accumulation that was independent of receptor-mediated adhesion mechanisms. Future studies are needed to determine if heat pulses with shorter periods, but higher intensity, could provide EC activation without affecting platelet function.
CONCLUSION
We developed a focal vascular injury model in which EC are activated by resistive heating of surface microelectrodes. EC could be differentially activated or killed as a function of the temperature at the millimeter length scale. Here, a simple electrode with a fixed width was used, but the same fabrication procedure could be used to define smaller or larger electrodes, or a series of electrodes within a single channel to define multiple activation zones. This model provides a tool for studying platelet interactions with subendothelial matrices in the presence of activated EC surrounded by quiescent EC. This is in contrast to the majority of in vitro flow assays that use either purified proteins or activation of entire surfaces of EC. The juxtaposition of quiescent and activated EC allows for future studies related to relative roles of pro-and antithrombotic function of EC as function of injury size, shear stress and EC activation state.
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